BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2009
View Archived Issues
Novel Flt3 inhibitors in early development at Biovitrum for proliferative disorders
Read More
Arpida and Evolva plan merger
Read More
Genfit progresses AD-Inov program in Alzheimer's disease
Read More
CytRx receives FDA letter regarding phase IIb arimoclomol trial in ALS
Read More
Affymax provides update for phase III Hematide program in chronic renal failure
Read More
Inviragen receives grant to support dengue vaccine development
Read More
QuatRx reports results of second pivotal phase III study of Ophena
Read More
NuPathe reports data from pivotal phase III Zelrix trial in acute migraine
Read More
Theravance and Astellas obtain FDA approval of Vibativ
Read More
Centocor Ortho Biotech receives two FDA Complete Response letters for Doxil combinations
Read More
Enrollment completed in phase III VEGF Trap-Eye studies in wet AMD
Read More
Cellerix's Cx-601 obtains EMEA orphan medicinal product status
Read More
StemCells to initiate neural stem cell trial in myelination disorder
Read More
GenSpera receives FDA approval to commence phase I G-202 trial in cancer
Read More
Atomoxetine improves symptoms of Parkinson's disease
Read More
LegoChem Biosciences describes novel cyclic amidrazone antibiotics
Read More
Details of phase II study with OP-145 in otitis media presented
Read More
Novel aminoglycoside ACHN-490 shows potent preclinical activity and clinical safety
Read More
Fatty acid synthase inhibitor UCM-Gi028 developed for anti-HER resistant cancer therapy
Read More
Long-term effects, cardiac safety and cognitive improvement assessed with fampridine-SR
Read More
Cephalon and Pharmacopeia describe histamine H3 receptor antagonists under development
Read More
New antibacterial compounds discovered by scientists at Princeton University
Read More
NovaBay and Galderma commence study of NVC-422 for impetigo
Read More
PTC Therapeutics initiates registration-directed phase III trial of ataluren in cystic fibrosis
Read More
Celldex Therapeutics doses first patient in phase I/II cancer vaccine trial
Read More
Verona reports final results of phase I/IIa RPL-554 trial in asthma
Read More